Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 11 studies | 54% ± 26% | |
| oligodendrocyte precursor cell | 9 studies | 46% ± 24% | |
| glutamatergic neuron | 7 studies | 48% ± 26% | |
| GABAergic neuron | 6 studies | 53% ± 23% | |
| microglial cell | 6 studies | 32% ± 16% | |
| oligodendrocyte | 6 studies | 39% ± 19% | |
| endothelial cell | 5 studies | 36% ± 17% | |
| epithelial cell | 4 studies | 32% ± 13% | |
| Mueller cell | 4 studies | 32% ± 12% | |
| amacrine cell | 4 studies | 35% ± 13% | |
| retina horizontal cell | 4 studies | 36% ± 14% | |
| retinal rod cell | 4 studies | 28% ± 6% | |
| interneuron | 4 studies | 72% ± 26% | |
| macrophage | 3 studies | 26% ± 9% | |
| GABAergic amacrine cell | 3 studies | 39% ± 9% | |
| glycinergic amacrine cell | 3 studies | 35% ± 4% | |
| retinal cone cell | 3 studies | 28% ± 10% | |
| retinal ganglion cell | 3 studies | 35% ± 21% | |
| fibroblast | 3 studies | 33% ± 16% | |
| lymphocyte | 3 studies | 26% ± 8% | |
| pericyte | 3 studies | 25% ± 7% | |
| smooth muscle cell | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1460.09 | 2642 / 2642 | 100% | 23.50 | 705 / 705 |
| esophagus | 100% | 749.62 | 1445 / 1445 | 100% | 7.51 | 183 / 183 |
| lung | 100% | 1091.40 | 578 / 578 | 100% | 9.76 | 1155 / 1155 |
| ovary | 100% | 1057.68 | 180 / 180 | 100% | 7.93 | 430 / 430 |
| breast | 100% | 938.65 | 459 / 459 | 100% | 8.96 | 1116 / 1118 |
| uterus | 100% | 975.45 | 170 / 170 | 100% | 9.13 | 457 / 459 |
| thymus | 100% | 1228.17 | 653 / 653 | 100% | 10.52 | 602 / 605 |
| prostate | 100% | 1219.81 | 245 / 245 | 99% | 7.92 | 498 / 502 |
| bladder | 100% | 778.81 | 21 / 21 | 99% | 7.08 | 497 / 504 |
| stomach | 100% | 591.12 | 359 / 359 | 98% | 5.58 | 281 / 286 |
| intestine | 100% | 803.46 | 966 / 966 | 98% | 5.45 | 517 / 527 |
| pancreas | 99% | 444.65 | 326 / 328 | 98% | 6.13 | 175 / 178 |
| kidney | 100% | 744.12 | 89 / 89 | 96% | 5.92 | 864 / 901 |
| skin | 100% | 935.48 | 1809 / 1809 | 96% | 7.80 | 452 / 472 |
| adrenal gland | 100% | 1066.19 | 258 / 258 | 96% | 6.71 | 220 / 230 |
| liver | 100% | 545.25 | 226 / 226 | 79% | 3.15 | 319 / 406 |
| adipose | 100% | 891.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 7.15 | 29 / 29 |
| spleen | 100% | 1293.98 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 7.06 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.19 | 1 / 1 |
| blood vessel | 100% | 707.20 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 511.82 | 838 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 302.38 | 752 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 90% | 552.14 | 834 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 80% | 3.39 | 64 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0055117 | Biological process | regulation of cardiac muscle contraction |
| GO_0036371 | Biological process | protein localization to T-tubule |
| GO_0030315 | Cellular component | T-tubule |
| GO_0005829 | Cellular component | cytosol |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ASB3 |
| Protein name | Ankyrin repeat and SOCS box protein 3 (ASB-3) Ankyrin repeat and SOCS box containing 3 |
| Synonyms | |
| Description | FUNCTION: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Recognizes TNFRSF1B. . |
| Accessions | ENST00000406053.5 ENST00000406687.5 [Q9Y575-2] H7BYZ6 ENST00000394717.3 [Q9Y575-2] Q9Y575 ENST00000406625.6 [Q9Y575-1] ENST00000263634.8 [Q9Y575-1] |